BD Medical, a division of Becton, Dickinson and Company, has introduced an anti-needlestick safety device in the US.

Designed to be used along with 1.0mL long BD Hypak or BD Neopak Glass prefilled syringes with staked needles, the FDA-cleared BD UltraSafe PLUS passive needle guard features a plunger rod to support injection of viscous drugs and a larger drug inspection window to improve drug visibility.

It also includes extended built-in finger flanges and an enhanced plunger head to support patients with diminished manual dexterity.

The company has studied patients with reduced dexterity, rheumatoid arthritis and multiple sclerosis during its clinical focus group trial.

Subjects in the study reported that the device provided ease of use with 100% of injections executed successfully, said the company.

BD Medical Pharmaceutical Systems president Claude Dartiguelongue said the new device complements the company’s existing safety portfolio.

"We now have an ergonomic safety device solution for those customers seeking to offer patients the ability to manually control their injection," Dartiguelongue added.

Originally developed by an anti-needlestick device company Safety Syringes, which was acquired by BD in December 2012, the device is also compatible with ISO standard prefilled syringes.

The company said the commercial shipments of the products are expected to be initiated in a due course.